Elsevier

Journal of Vascular Surgery

Volume 72, Issue 6, December 2020, Pages 1850-1855
Journal of Vascular Surgery

COVID-19 and vascular disease
Impact of the coronavirus disease 2019 pandemic on an academic vascular practice and a multidisciplinary limb preservation program

https://doi.org/10.1016/j.jvs.2020.08.132Get rights and content
Under an Elsevier user license
open archive

Abstract

With the aggressive resource conservation necessary to face the coronavirus disease 2019 pandemic, vascular surgeons have faced unique challenges in managing the health of their high-risk patients. An early analysis of patient outcomes after pandemic-related practice changes suggested that patients with chronic limb threatening ischemia have been presenting with more severe foot infections and are more likely to require major limb amputation compared with 6 months previously. As our society and health care system adapt to the new changes required in the post–coronavirus disease 2019 era, it is critical that we pay special attention to the most vulnerable subsets of patients with vascular disease, particularly those with chronic limb threatening ischemia and limited access to care.

Key words

Chronic limb threatening ischemia
COVID-19
Decision support
Medical decision making
Triage

Cited by (0)

Author conflict of interest: J.A.S. is a member of the Data Monitoring Committee of the Medullary Thyroid Cancer Consortium Registry supported by GlaxoSmithKline, Novo Nordisk, AstraZeneca, and Eli Lilly and has also received institutional research funding from Loxo/Lilly and Exelixis. E.M.L., B.W., J.I., A.O., W.G., S.V., E.W., J.H., C.E., E.L., A.R., L.R., and M.S.C. have no conflicts of interest.

The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest.